ARCHIVES

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004

Working Group Considering formal Cap On size of Cancer Center Support Grants

March 22, 1996

AACI Adopts Plan To Step Up Cancer Issues Involvement

January 25, 1980

Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older

June 25, 2010

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

October 28, 2005

NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”

October 23, 1981